Group 1 - The core viewpoint of the article highlights the growing investment interest in the innovative pharmaceutical sector, which has led to the emergence of three actively managed equity funds that have doubled their returns this year [1] - The fund "Changcheng Medical Industry Selection" leads the year-to-date performance among actively managed equity funds with a return of 119.66% [1] - Other funds, "Yongying Medical Innovation Smart Selection" and "Bank of China Hong Kong Stock Connect Medical," have also shown impressive returns of 106.37% and 105.43% respectively [1]

Core Viewpoint - The article discusses the introduction of floating management fee rate actively managed equity funds by multiple fund companies in response to the China Securities Regulatory Commission's action plan for promoting high-quality development of public funds by May 2025. It explains how the management fees for these funds are structured and calculated. Summary by Sections Management Fee Structure - The management fee for the new floating rate funds consists of three components: fixed management fee, contingent management fee, and excess management fee [2][3] - The applicable management fee rate depends on the holding period and annualized return of the fund shares at the time of redemption or transfer [2] Fee Calculation Example - An example is provided where the critical holding period is set at one year, with performance thresholds of 6% for outperformance and 3% for underperformance against the benchmark. The fixed, contingent, and excess management fees are set at 0.6% per year, 0.6% per year, and 0.3% per year, respectively [3][6] Fee Collection Process - The management fees are deducted daily based on the previous day's net asset value of the fund. The net asset value seen by investors is after deducting these fees [7] - If the holding period is less than one year, a management fee of 1.20% per year is charged. If the holding period is one year or more, the fee is determined based on the annualized return during the holding period [7][9] Specific Fee Scenarios - Three scenarios are outlined for fee determination: 1. If the annualized return exceeds the benchmark return by more than 6% and is positive, a total fee of 1.50% per year is charged [9] 2. If the annualized return is below the benchmark return by 3% or more, only the fixed management fee of 0.6% per year is charged, with the contingent fee refunded [9] 3. In other cases, a management fee of 1.20% per year is applied [9]

Core Viewpoint - The article highlights the performance of actively managed equity funds in the context of a recovering equity market, noting a significant disparity in performance among funds, leading to varied experiences for investors [1][2]. Fund Performance and Management - Over the past decade (2015-2024), only one actively managed equity fund has consistently outperformed the CSI 300 Index, which represents core assets in the A-share market [3]. - The fund that achieved this is the Dachen Selected Value Fund, managed by Li Bo, who is known for his "steady growth" investment style, primarily focusing on large-cap value stocks [4][5]. - Since Li Bo took over the fund on November 4, 2016, it has achieved a total return of 96.64% as of March 31, 2025 [5]. - Li Bo maintains a stable equity position of 80%-90%, with performance mainly driven by stock selection rather than frequent trading [7]. Portfolio Composition - As of the end of Q1 2025, the top ten holdings of the Dachen Selected Value Fund include leading companies across various sectors, such as Midea Group, China Mobile, and Gree Electric [8][9]. - The fund's turnover rate has decreased from nearly 200% to below 100% from its early years under Li Bo's management, indicating a more stable investment approach [9]. Risk Management - The Dachen Selected Value Fund has demonstrated strong risk management, with a maximum drawdown of only 14% over the past three years, which is commendable in a volatile market environment [11]. - Research indicates that the fund has lower maximum drawdowns compared to the CSI Index during various market downturns, showcasing its resilience [12]. Investment Philosophy - Li Bo's investment philosophy emphasizes deep research and understanding of company growth drivers, moving beyond mere quantitative metrics to a more qualitative assessment of companies [15][16]. - His investment approach has evolved through three stages, focusing first on growth, then on sustainable growth through company capabilities, and finally incorporating common sense and industry knowledge into investment decisions [21][22][23]. Fund Size and Capacity - Li Bo currently manages two public funds with a combined scale exceeding 3.8 billion yuan, along with additional assets under management totaling over 4.6 billion yuan, indicating ample capacity for sustainable excess returns [17].

Core Viewpoint - The A-share market experienced a volatile first half of 2025, with the Shanghai Composite Index slightly up by 2.76%, while the Shenzhen Component Index and the ChiNext Index saw gains of around 0.5%. The CSI 2000, representing small-cap stocks, performed notably well with over 15% growth [1]. Group 1: Active Equity Funds Performance - A total of 7,285 active equity funds reported performance for the first half of 2025, with an average return of 7.32% and a median return of 5.33%, outperforming the three major A-share indices [1]. - Among these funds, 53 achieved returns exceeding 50% [1]. Group 2: Funds Over 100 Billion - In the category of active equity funds with over 100 billion yuan, 19 funds were identified, with notable performances from funds managed by Xie Zhiyu and Ge Lan [2]. - The top five funds in this category had returns ranging from 3.63% to 15.85%, all surpassing the Shanghai Composite Index [2]. Group 3: Fund Details Over 100 Billion - The leading fund, "Xingquan He Yi LOF" managed by Xie Zhiyu and Xue Yiran, reported a return of 15.85% with a scale of approximately 144.89 billion yuan, and a cumulative return of 62.31% since its inception [6]. - The top holdings of this fund included major tech companies such as Xiaomi, Alibaba, and Tencent [6]. Group 4: Funds Between 50-100 Billion - In the 50-100 billion yuan category, 43 active equity funds were analyzed, with the top five funds achieving returns from 11.58% to 49.04% [10]. - The leading fund in this group was managed by Penghua Fund, with a return of 49.04% [12]. Group 5: Funds Between 20-50 Billion - For funds in the 20-50 billion yuan range, 338 funds were evaluated, with the top five funds achieving returns from 33% to 54.08% [15]. - The top fund, "Zhongyin Chuangxin Yiliao," managed by Zheng Ning, reported a return of 54.08% [19]. Group 6: Funds Between 10-20 Billion - In the 10-20 billion yuan category, 447 funds were assessed, with the top five funds primarily focused on the pharmaceutical sector [20]. - The leading fund in this group was managed by Ping An Fund, achieving a return of 56.97% [21]. Group 7: Funds Between 5-10 Billion - The 5-10 billion yuan category included 675 funds, with the top five funds showing returns from 57.41% to 72.16% [26]. - The top fund, "Hua Xia Bei Jiao Suo Chuang Xin," reported a return of 72.16% [25]. Group 8: Funds Between 1-5 Billion - In the smallest category of 1-5 billion yuan, 2022 funds were analyzed, with the top five funds achieving returns from 57.11% to 82.45% [26]. - The leading fund, "Zhongxin Jiantou Bei Jiao Suo Jing Xuan," reported an impressive return of 82.45% [30].

Group 1 - The core viewpoint of the article highlights the performance of various sectors such as innovative drugs, humanoid robots, the Beijing Stock Exchange, and new consumption trends, which have driven market momentum and generated significant investment returns [1] - Notably, many actively managed equity funds have demonstrated a remarkable turnaround in performance, with nearly a hundred funds reaching their highest net value since inception in June [1]

Group 1 - Several floating rate funds have been announced today, with total establishment sizes exceeding 600 million yuan, including E Fund Growth Progress exceeding 1.7 billion yuan [1][2] - The established floating rate funds have begun building positions, with some funds showing significant movements shortly after their establishment [1][4] - The cumulative establishment size of five floating rate funds has surpassed 6 billion yuan [3] Group 2 - New funds established in the second quarter have shown notable building actions, with over 1,000 million yuan in total establishment size for stock and mixed funds [5][6] - Among the new funds, some have already exceeded 50% in stock asset allocation within a short time frame [6] - The top holdings of newly established funds indicate a concentration in the banking sector, benefiting from recent strong performance in that sector [6][7]

Group 1 - The A-share market has shown a rebound since April 7, with the Wind偏股混合型基金指数 rising over 11% as of June 17, indicating a recovery in active equity products [1][2] - Nearly 70% of active equity funds have turned positive in returns, with 3,079 out of 4,462 funds reporting gains, a significant increase from 10.8% on April 7 [2][3] - The top-performing funds are heavily invested in the pharmaceutical sector, with six out of the top ten funds focusing on this area, driven by Hong Kong innovative drug stocks [3][5] Group 2 - The top fund, 长城医药产业精选A, has achieved a 75.69% return year-to-date, followed closely by 中信建投北交所精选两年定开A and 永赢医药创新智选A with returns of 74% and 70.8% respectively [3] - The performance of the pharmaceutical sector is attributed to the strong showing of Hong Kong innovative drug stocks, which constitute a significant portion of the holdings in these funds [3][6] - Despite recent market corrections in popular sectors like innovative drugs and new consumption, industry experts believe that the long-term value remains intact, with ongoing support from national policies and market demand [5][6] Group 3 - The innovative drug sector has seen a year-to-date increase of 59.18%, while other sectors like humanoid robots and new consumption have also performed well, with gains exceeding 20% [5] - Recent corrections in these sectors are viewed as technical adjustments rather than a sign of a downturn, with analysts suggesting continued investment interest in innovative drugs due to their long-term growth potential [6][7] - The new consumption sector is experiencing a temporary pullback, but the underlying market conditions remain strong, as evidenced by positive consumption data during the recent 618 shopping festival [6][7]

Core Insights - The active equity funds have shown a dramatic contrast in performance amidst rising capital market volatility, with the first "doubling fund" emerging in the year, igniting market enthusiasm, while new fund issuance remains relatively subdued [1][3] - As of June 13, the "Huitianfu Hong Kong Advantage Selected Mixed A/C" fund achieved a year-to-date return exceeding 100%, becoming a market highlight, while 16 active equity funds have returns over 70% [3][4] - Despite strong performance from some funds, the new issuance of active equity funds has been lackluster, with a total of 299.16 billion yuan raised in new funds this year, accounting for only 6.56% of the total public offering new issuance [5][6] Fund Performance - The first "doubling fund" appeared in the active equity market, with the "Huitianfu Hong Kong Advantage Selected Mixed" fund showing a year-to-date increase of over 100% [3] - Other notable funds include "Changcheng Medical Industry Selected Mixed" with over 87% return and "Yongying Medical Innovation Smart Selection" with over 79% return [3] - The overall average return for active equity funds this year is 2.87%, with a significant disparity of 132.35 percentage points between the best and worst performers [3][4] Fund Issuance - A total of 89 new active equity funds were established this year, with the largest fund being "Oriental Red Core Value Mixed" at 19.91 billion yuan [5][6] - 32 active equity funds had issuance sizes below 1 billion yuan, indicating a trend towards smaller fund launches [5] - The failure of the "Shenwan Lingshin Vision Growth Mixed" fund to meet fundraising conditions highlights challenges in the current market environment [6] Market Outlook - Analysts suggest that the key to breaking the current stagnation in new fund issuance lies in enhancing asset allocation capabilities and improving net value performance [7][8] - The recent reforms in public funds emphasize the alignment of fund company income with investor returns, which may enhance the attractiveness of existing products and instill confidence in new offerings [8] - Future issuance of active equity funds may improve as market conditions stabilize and investor confidence returns, with a focus on optimizing product design and enhancing service quality [8][9]

Quantitative Models and Construction Methods 1. Model Name: Brinson Attribution Model - **Model Construction Idea**: The model is used to decompose the excess returns of active equity funds into stock selection and sector allocation contributions, providing insights into the sources of fund performance [16][19][22] - **Model Construction Process**: The Brinson model calculates excess returns as follows: $ R_{excess} = \sum_{i=1}^{n} (W_{i,f} - W_{i,b}) \cdot R_{i,b} + \sum_{i=1}^{n} W_{i,f} \cdot (R_{i,f} - R_{i,b}) $ - $ W_{i,f} $: Fund weight in sector $ i $ - $ W_{i,b} $: Benchmark weight in sector $ i $ - $ R_{i,f} $: Fund return in sector $ i $ - $ R_{i,b} $: Benchmark return in sector $ i $ The first term represents the allocation effect, and the second term represents the selection effect [16][19] - **Model Evaluation**: The model highlights that stock selection contributes more significantly to excess returns than sector allocation, with stock selection accounting for 83.17% of the total contribution on average [16][22] --- Model Backtesting Results 1. Brinson Attribution Model - Average stock selection contribution: 5.38% per half-year [22] - Probability of positive stock selection returns: 69.12% [23] - Probability of positive sector allocation returns: 53.66% [23] --- Quantitative Factors and Construction Methods 1. Factor Name: Fund Stability Factor - **Factor Construction Idea**: This factor measures the stability of a fund's sector allocation and its impact on outperforming benchmarks [10][12] - **Factor Construction Process**: Funds are categorized into 16 groups based on static and dynamic sector allocation characteristics: - Static categories: Highly diversified, diversified, concentrated, highly concentrated - Dynamic categories: Highly stable, stable, rotational, highly rotational The average probability of outperforming benchmarks is calculated for each group [10][12] - **Factor Evaluation**: Funds with highly stable and diversified sector allocations have the highest probability of outperforming benchmarks, exceeding 73% on average [12][14] 2. Factor Name: Style Consistency Factor - **Factor Construction Idea**: This factor evaluates the consistency of a fund's style (e.g., large-cap value) and its correlation with performance [27][30] - **Factor Construction Process**: Funds are classified based on their style consistency over time: - Long-term stable allocation - Majority-time allocation - Partial-time allocation - Rare-time allocation The probability of outperforming benchmarks is calculated for each group [27][28] - **Factor Evaluation**: Funds with long-term stable large-cap value styles have the highest probability of outperforming benchmarks, reaching 79.77% [28][30] --- Factor Backtesting Results 1. Fund Stability Factor - Highly diversified-highly stable funds: - Probability of outperforming benchmark: 73.12% - Probability of outperforming benchmark +10%: 57.29% [12] 2. Style Consistency Factor - Long-term stable large-cap value funds: - Probability of outperforming benchmark: 79.77% - Probability of outperforming benchmark +10%: 69.05% [28]

Core Viewpoint - The TOP 100 active equity fund manager list has consistently outperformed the Wind偏股基金指数 for four consecutive years, indicating the value of excellent active equity fund managers [1][2]. Group 1: Performance of Fund Managers - The TOP 100 list includes fund managers who have shown the ability to outperform their peers, with a specific focus on those managing Hong Kong stocks [4][9]. - The performance of the Hong Kong fund managers from the TOP 100 list yielded a return of 22.89% as of May 28, 2025, compared to the Hang Seng Index's 17.45% and the active Hong Kong fund index's 13.61% [9]. - Despite the success of individual fund managers, the overall active equity funds in the Hong Kong market struggle to outperform the index, similar to trends in other mature markets [9][10]. Group 2: Notable Fund Managers - Zhang Feng from 富国基金 has over 25 years of experience and has built a strong reputation in the Hong Kong market, with his fund 富国中国中小盘 being one of the top performers [12][13][14]. - Ning Jun, also from 富国基金, has a broad investment style and has managed funds that have consistently performed well, including 富国沪港深业绩驱动 [20][24]. - Bai Yang from 大成国际 has a strong academic background and has received multiple awards for his performance, managing funds that rank well in the Hong Kong market [33][41]. - Luo Jiaming, with 18 years of experience in Hong Kong, has a quality-focused investment style, but his recent performance has been disappointing due to market conditions [43][49]. - Xiong Xiaoya from 南方基金 has shown promising results with her growth-oriented investment style, although her team's recent changes may impact future performance [56][59]. - Zhang Jintao from 嘉实基金 has a value-oriented investment approach and has managed funds with solid performance, although his large management scale may affect focus [63][66]. Group 3: Market Insights - The Hong Kong market is characterized by concentrated liquidity, making it challenging for active fund managers to consistently outperform the index [9]. - The article emphasizes the importance of selecting fund managers with proven track records and the ability to navigate the complexities of the Hong Kong market [4][9].